04:28 PM EDT, 05/19/2025 (MT Newswires) -- Michael W Bonney, Director, on May 15, 2025, sold 11,250 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,124,217. Following the Form 4 filing with the SEC, Bonney has control over a total of 20,804 common shares of the company, with 16,804 shares held directly and 4,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000072/xslF345X05/edgardoc.xml